Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.

Technetium-99m (99mTc) (v) dimercaptosuccinic acid (DMSA) is a new tumour-imaging agent which has been used to image head and neck squamous carcinoma. This study used an established rabbit tumour model to compare palpation versus planar scintigraphy in the detection of superficially transplanted cancers. Palpation detected 83% of tumours measuring less than 2 cm compared with 58% for scintigraphy. Overall, the sensitivity for palpation was 88% (77% specificity) compared with 50% (63% specificity) for scintigraphy.

[1]  D. Johnston,et al.  The reliability of palpation in the assessment of tumours. , 1990, Clinical otolaryngology and allied sciences.

[2]  J. Watkinson,et al.  What is the optimal imaging time for 99Tcm-(v)-DMSA planar scintigraphy in the detection of squamous carcinoma ? A comparative study in humans and in an animal tumour model , 1989, Nuclear medicine communications.

[3]  J. Watkinson,et al.  Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J. Watkinson,et al.  Imaging Head and Neck Cancer Using Radioisotopes: A Review , 1988, Journal of the Royal Society of Medicine.

[5]  J. Watkinson,et al.  An evaluation of the uptake of technetium-99m (v) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck. , 1987, Clinical otolaryngology and allied sciences.

[6]  D. Euhus,et al.  Tumor measurement in the nude mouse , 1986, Journal of surgical oncology.

[7]  E. Woodward,et al.  Parathormone Bio-Assay of Plasma in Hypercalcemic Tumor Rabbits.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.